Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
CuriosityStream | CURI | Jun 24, 2024 | 1.17 | -1.68 |
Curis | CRIS | Jun 24, 2024 | 8.20 | +3.02 |
Curtiss-Wright | CW | Jun 24, 2024 | 275.39 | +0.14 |
Cushing Mlp & Infrastructure Total Return Fund | SRV | Jun 24, 2024 | 41.95 | +0.12 |
Cushman & Wakefield | CWK | Jun 24, 2024 | 10.56 | -2.85 |
Custom Truck One Source | CTOS | Jun 24, 2024 | 4.44 | +0.45 |
Customers Bancorp | CUBI | Jun 24, 2024 | 46.75 | +2.93 |
Customers Bancorp E Pref | CUBI-E | Jun 24, 2024 | 25.67 | +0.21 |
Customers Bancorp F Pref | CUBI-F | Jun 24, 2024 | 25.38 | -0.01 |
Cutera | CUTR | Jun 24, 2024 | 1.38 | -10.39 |
CVB Financial | CVBF | Jun 24, 2024 | 16.70 | +1.77 |
CVD Equipment | CVV | Jun 24, 2024 | 3.84 | -2.78 |
CVR Energy | CVI | Jun 24, 2024 | 26.71 | -0.45 |
Cvr Partners LP Unit | UAN | Jun 24, 2024 | 76.01 | +0.50 |
CVRx | CVRX | Jun 24, 2024 | 10.68 | -1.29 |
CVS Health | CVS | Jun 24, 2024 | 61.73 | +0.59 |
CXApp A | CXAI | Jun 24, 2024 | 2.11 | -7.46 |
CyberArk Software | CYBR | Jun 24, 2024 | 261.34 | +1.29 |
Cybin | CYBN | Jun 24, 2024 | 0.26 | 0.00 |
Cyclacel Pharmaceuticals | CYCC | Jun 24, 2024 | 1.66 | -5.01 |
Cyclacel Pharmaceuticals Pref | CYCCP | Jun 24, 2024 | 7.49 | 0.00 |
Cyclerion Therapeutics | CYCN | Jun 24, 2024 | 2.87 | +6.69 |
Cyclo Therapeutics | CYTH | Jun 24, 2024 | 1.18 | -9.23 |
Cyngn | CYN | Jun 24, 2024 | 0.07 | -5.26 |
Cytek Biosciences | CTKB | Jun 24, 2024 | 5.60 | -2.27 |
Cytokinetics | CYTK | Jun 24, 2024 | 53.90 | +0.71 |
Cytomed Therapeutics | GDTC | Jun 24, 2024 | 2.07 | +4.55 |
CytomX Therapeutics | CTMX | Jun 24, 2024 | 1.33 | +3.10 |
Cytosorbents | CTSO | Jun 24, 2024 | 0.77 | -3.65 |
D-MARKET Electronic Services & Trading ADR | HEPS | Jun 24, 2024 | 1.97 | +0.51 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.